Clinical Trial

Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity

Name: Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity — clinical trial record (NCT07387679)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.

Trial Details

NCT Number	NCT07387679
Lead Sponsor	Muhammad Aamir Latif
Conditions	Polycystic Ovarian Syndrome
Enrollment	60 participants
Start Date	2024-11-29
Primary Completion	2025-05-28 (estimated)
Study Completion	2025-05-28 (estimated)
Updated on ClinicalTrials.gov	2026-02-04